Details of the Drug Reposition

General Information of This Drug (ID: DM6WN2D)

Drug Name
ABT-308   DM6WN2D

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Eosinophilic esophagitis DISR8WSB DA24.1 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Asthma DISW9QNS CA23 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT00986037) Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma. U.S. National Institutes of Health.